近視和老花眼眼藥水市場：按眼藥水類型、適應症、最終用戶和地區分類。

Myopia And Presbyopia Eye Drops Market, By Eye Drops, By Indication, By End User, By Geography

出版日期: 2026年06月25日 | 出版商:

Coherent Market Insights | 英文 253 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，近視和老花眼眼藥水市場規模將達到 16.4 億美元，到 2033 年將達到 26.3 億美元。預計 2026 年至 2033 年的複合年成長率將達到 7.5%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	16.4億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	7.50%	預計金額（2033 年）	26.3億美元

老花眼是一種眼部疾病，患者近距離視物能力逐漸下降。這是與老齡化相關的正常現象。近視也是一種常見的眼部疾病，會導致視力下降，而未矯正的近視是全球遠視力障礙的主要原因之一。多項研究表明，高度近視和近視的盛行率因地區和種族而異，近視盛行率不斷上升的趨勢仍存在不確定性。此外，市場參與企業正致力於非有機成長策略，例如透過合作來提高大眾對兒童近視的認知，預計這將推動預測期內的市場成長。例如，2020年10月，Myopia Profile Pty Ltd和依視路國際達成合作協議，旨在為眼科醫護人員提供有關兒童近視管理的技能、臨床知識和實踐方法。此次合作也將有助於提高大眾對近視危害的認知，並鼓勵家長帶孩子進行視力檢查。

市場動態

研究人員正集中研發利用新技術開發近視和老花眼的新療法，預計將推動全球近視和老花眼眼藥水市場在預測期內的成長。例如，2019年1月，以色列巴伊蘭大學奈米技術與先進材料研究所（BINA）研發了一種名為「Nanodrop」的屈光，用於矯正屈光不正（如近視和老花眼）引起的視力問題。這種滴眼液由合成奈米顆粒溶液組成，並使用豬角膜進行了測試。研究人員報告稱，該滴眼液改善了豬的兩種屈光不正：近視和老花眼。

本報告的主要特點

本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
本頁面根據各種參數（公司概況、產品系列、主要趨勢、財務表現、策略等）對全球近視和老花眼藥水市場的主要公司進行了介紹。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
《全球近視和老花眼藥水市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球近視和老花眼藥水市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Orasis Pharmaceuticals
- AbbVie Inc.（Allergan）
- Novartis AG
- OSRX Pharmaceuticals
- LENZ Therapeutics
- Visus Therapeutics
- Ocuphire Pharma Inc.
- Eyenovia, Inc.
- Vyluma Inc.
- Jawa Pharmaceuticals（India）Pvt. Ltd.
分析師意見

第9章

參考
分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI4633

Myopia And Presbyopia Eye Drops Market is estimated to be valued at USD 1.64 Bn in 2026 and is expected to reach USD 2.63 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1.64 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.50%	2033 Value Projection:	USD 2.63 Bn

Presbyopia is an eye disorder, in which one's eyes gradually lose the ability to see things clearly up close distances. It is a normal part of aging. In addition, myopia is a common eye disorder that cause vision loss, and uncorrected myopia is amongst the leading cause of distance vision impairment worldwide. Several individual studies have shown variations in the prevalence of high myopia and myopia in regions and ethnic groups, and there continues to be uncertainty regarding increasing prevalence of myopia. Moreover, market players are focused on inorganic strategies such as partnerships, in order to increase awareness about childhood myopia which in turn is expected to boost the market growth over the forecast period. For instance, in October 2020, Myopia Profile Pty Ltd and Essilor International entered into a partnership agreement for empowering eye care practitioners with skills, clinical knowledge, and practice in managing childhood myopia. The partnership will also boost public awareness of the consequences of myopia, also called near sightedness, and in addition, this will also encourage parents to have their children's vision tested.

Market Dynamics

Researchers are focusing on research and development activities for the development of new treatment for myopia and presbyopia, by using new technologies, which is expected to drive growth of the global myopia & presbyopia eye drops market over the forecast period. For instance, in January 2019, Bar-Ilan University's Institute of Nanotechnology and Advanced Materials (BINA), Israel, developed eye drops called as 'nanodrops' for correcting the refractive-related vision problems such as myopia and presbyopia. The eye drops are made up of a synthetic nanoparticle solution and have been tested on pig's cornea. The researchers reported that the drops treated two kinds of refractive errors: myopia and presbyopia in pigs.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global myopia & presbyopia eye drops market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include Orasis Pharmaceuticals, AbbVie Inc. (Allergan), Novartis AG, OSRX Pharmaceuticals, LENZ Therapeutics, Visus Therapeutics, Ocuphire Pharma Inc., Eyenovia, Inc., Vyluma Inc., and Jawa Pharmaceuticals (India) Pvt. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global myopia & presbyopia eye drops market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global myopia & presbyopia eye drops market

Market Segmentation

By Eye Drops (Revenue, USD Bn, 2021-2033)
Atropine Drops
Pipeline Products
- CSF-1
- AGN - 190584
- Nyxol
- UNR844-Cl
- PRX-100
- MicroLine
- Others
By Indication (Revenue, USD Bn, 2021-2033)
Myopia
Presbyopia
By End User (Revenue, USD Bn, 2021-2033)
Hospitals
Ophthalmic Clinics
Others
By Region (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
Orasis Pharmaceuticals
AbbVie Inc. (Allergan)
Novartis AG
OSRX Pharmaceuticals
LENZ Therapeutics
Visus Therapeutics
Ocuphire Pharma Inc.
Eyenovia, Inc.
Vyluma Inc.
Jawa Pharmaceuticals (India) Pvt. Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Eye Drops
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Myopia And Presbyopia Eye Drops Market, By Eye Drops, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Atropine Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Pipeline Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  - CSF-1
  - AGN-190584
  - Nyxol
  - UNR844-Cl
  - PRX-100
  - MicroLine
  - Others

5. Myopia And Presbyopia Eye Drops Market, By Indication, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Myopia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Presbyopia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Myopia And Presbyopia Eye Drops Market, By End User, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Ophthalmic Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Myopia And Presbyopia Eye Drops Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Orasis Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- AbbVie Inc. (Allergan)
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- OSRX Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- LENZ Therapeutics
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Visus Therapeutics
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Ocuphire Pharma Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Eyenovia, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Vyluma Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Jawa Pharmaceuticals (India) Pvt. Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views